Skip to main content

Main menu

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Instructions for authors
  • About the journal
    • About the journal
    • Editorial board
    • Instructions for authors
    • FAQs
    • Chinese Stroke Association
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
  • BMJ Journals

User menu

  • Login

Search

  • Advanced search
  • BMJ Journals
  • Login
  • Facebook
  • Twitter
Stroke and Vascular Neurology

Advanced Search

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Instructions for authors
  • About the journal
    • About the journal
    • Editorial board
    • Instructions for authors
    • FAQs
    • Chinese Stroke Association
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
Open Access

Shuxuetong for Prevention of recurrence in Acute Cerebrovascular events with Embolism (SPACE) trial: rationale and design

Hong-Qiu Gu, Xue-Wei Xie, Jing Jing, Xia Meng, Wei Lv, Jian-Dong Yu, Xiang-Ping Lv, Hao Li, Yi-Long Wang, Yong-Jun Wang
DOI: 10.1136/svn-2019-000293 Published 27 February 2020
Hong-Qiu Gu
1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hong-Qiu Gu
Xue-Wei Xie
1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Jing
1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xia Meng
1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Lv
1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian-Dong Yu
1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiang-Ping Lv
1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hao Li
1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hao Li
Yi-Long Wang
1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2Vascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong-Jun Wang
1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2Vascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
3Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
4Center for Stroke, Beijing Institute for Brain Disorders, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yong-Jun Wang
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1136/svn-2019-000293
PubMed 
32994371

Print ISSN 
2059-8688
Online ISSN 
2059-8696
History 
  • Received October 21, 2019
  • Revised November 23, 2019
  • Accepted December 6, 2019
  • Published online February 27, 2020.

Article Versions

  • You are currently viewing a Previous version of this article (February 27, 2020 - 19:54).
  • View the most recent version of this article
Copyright & Usage 
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Author Information

  1. Hong-Qiu Gu1,
  2. Xue-Wei Xie1,
  3. Jing Jing1,
  4. Xia Meng1,
  5. Wei Lv1,
  6. Jian-Dong Yu1,
  7. Xiang-Ping Lv1,
  8. Hao Li1,
  9. Yi-Long Wang1,2,
  10. Yong-Jun Wang1,2,3,4
  1. 1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  2. 2Vascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  3. 3Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
  4. 4Center for Stroke, Beijing Institute for Brain Disorders, Beijing, China
  1. Correspondence to Dr Yong-Jun Wang; yongjunwang{at}ncrcnd.org.cn
View Full Text

Article usage

Article usage: February 2020 to May 2025

AbstractFullPdf
Feb 2020565527
Mar 2020383614
Apr 202016168
May 202023247
Jun 202018187
Jul 2020222212
Aug 2020312418
Sep 2020575712
Oct 2020838135
Nov 2020717029
Dec 2020393818
Jan 2021393720
Feb 2021454316
Mar 2021312915
Apr 2021242410
May 2021312826
Jun 2021262513
Jul 2021212114
Aug 2021262624
Sep 2021222217
Oct 2021424231
Nov 2021242323
Dec 202126259
Jan 20221561552
Feb 202228309
Mar 2022292912
Apr 202230304
May 2022353722
Jun 2022292910
Jul 202233338
Aug 202229305
Sep 2022352815
Oct 2022343410
Nov 2022404010
Dec 202237385
Jan 2023151613
Feb 202355559
Mar 202327267
Apr 202316177
May 2023222115
Jun 202318184
Jul 202316168
Aug 202324247
Sep 2023353513
Oct 2023232211
Nov 202344446
Dec 202362579
Jan 2024262612
Feb 202418186
Mar 2024404020
Apr 202427268
May 2024202013
Jun 2024353212
Jul 2024292611
Aug 2024202013
Sep 2024241913
Oct 2024232312
Nov 202413139
Mar 2025110
Apr 20253432
May 202521510

Statistics from Altmetric.com

PreviousNext
Back to top
Vol 10 Issue 1 Table of Contents
Stroke and Vascular Neurology: 10 (1)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Email

Thank you for your interest in spreading the word on Stroke and Vascular Neurology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Shuxuetong for Prevention of recurrence in Acute Cerebrovascular events with Embolism (SPACE) trial: rationale and design
(Your Name) has sent you a message from Stroke and Vascular Neurology
(Your Name) thought you would like to see the Stroke and Vascular Neurology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Shuxuetong for Prevention of recurrence in Acute Cerebrovascular events with Embolism (SPACE) trial: rationale and design
Hong-Qiu Gu, Xue-Wei Xie, Jing Jing, Xia Meng, Wei Lv, Jian-Dong Yu, Xiang-Ping Lv, Hao Li, Yi-Long Wang, Yong-Jun Wang
Stroke and Vascular Neurology Feb 2020, svn-2019-000293; DOI: 10.1136/svn-2019-000293

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Cite This
  • APA
  • Chicago
  • Endnote
  • MLA
Loading
Shuxuetong for Prevention of recurrence in Acute Cerebrovascular events with Embolism (SPACE) trial: rationale and design
Hong-Qiu Gu, Xue-Wei Xie, Jing Jing, Xia Meng, Wei Lv, Jian-Dong Yu, Xiang-Ping Lv, Hao Li, Yi-Long Wang, Yong-Jun Wang
Stroke and Vascular Neurology Feb 2020, svn-2019-000293; DOI: 10.1136/svn-2019-000293
Download PDF

Share
Shuxuetong for Prevention of recurrence in Acute Cerebrovascular events with Embolism (SPACE) trial: rationale and design
Hong-Qiu Gu, Xue-Wei Xie, Jing Jing, Xia Meng, Wei Lv, Jian-Dong Yu, Xiang-Ping Lv, Hao Li, Yi-Long Wang, Yong-Jun Wang
Stroke and Vascular Neurology Feb 2020, svn-2019-000293; DOI: 10.1136/svn-2019-000293
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Article
    • Abstract
    • Introduction and rationale
    • Methods
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Rationale and Study Design to Assess the Efficacy and Safety of Minocycline in Patients with Moderate to Severe Acute Ischaemic Stroke (EMPHASIS)
  • Role of histone deacetylases and sirtuins in the ischaemic stroke: a protocol for a systematic review and meta-analysis of animal studies
  • Efficacy and safety of Ferrous iron on the prevention of Vascular cOgnitive impaiRment among patients with cerebral Infarction/TIA (FAVORITE): rationale and design of a multicentre randomised trial
Show more Protocol

Similar Articles

 
 

CONTENT

  • Latest content
  • Current issue
  • Archive
  • eLetters
  • Sign up for email alerts
  • RSS

JOURNAL

  • About the journal
  • Editorial board
  • Recommend to librarian
  • Chinese Stroke Association

AUTHORS

  • Instructions for authors
  • Submit a paper
  • Track your article
  • Open Access at BMJ

HELP

  • Contact us
  • Reprints
  • Permissions
  • Advertising
  • Feedback form

© 2025 Chinese Stroke Association